{"filing":{"accession_number":"0001628280-26-039189","cik":"0001447362","ticker":"CSTL","company_name":"CASTLE BIOSCIENCES INC","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"cstl-20260528.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1447362/000162828026039189/cstl-20260528.htm"},"events":[{"id":8240,"run_id":7231,"accession_number":"0001628280-26-039189","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of Castle Biosciences' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for four proposals: election of three Class I directors (Ellen Goldberg, Miles D. Harrison, Tiffany P. Olson), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the non-employee director compensation policy. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.","company_name":"CASTLE BIOSCIENCES INC","ticker":"CSTL","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2872,"accession_number":"0001628280-26-039189","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Castle Biosciences' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for four proposals: election of three Class I directors (Ellen Goldberg, Miles D. Harrison, Tiffany P. Olson), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the non-employee director compensation policy. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:38:54.646832+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2872,"accession_number":"0001628280-26-039189","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Castle Biosciences' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for four proposals: election of three Class I directors (Ellen Goldberg, Miles D. Harrison, Tiffany P. Olson), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the non-employee director compensation policy. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:38:54.646832+00:00","company_name":"CASTLE BIOSCIENCES INC","ticker":"CSTL","filing_date":"2026-05-29"}]}